This announcement is a separate document:
昭栄薬品:2024年3月期 第2四半期決算短信〔日本基準〕(連結)
Shoei Yakuhin: Summary of Financial Results for the 2nd Quarter Ending March 2024 [Japanese GAAP] (Consolidated)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.